For citations:
Shnayder N.A., Bader V.V., Pekarets N.A., Bykov Yu.A., Shirukova A.M., Nasyrova R.F. Pharmacogenomics and pharmacometabolomics of levetiracetam in personalized neurotoxicity risk assessment. Epilepsy and paroxysmal conditions. 2026;18(2):158–172. (In Russ.) https://doi.org/10.17749/2077-8333/epi.par.con.2026.274
JATS XML
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 